Literature DB >> 16300272

The role of peritoneal fibrosis in encapsulating peritoneal sclerosis.

Masanobu Miyazaki1, Yukio Yuzawa.   

Abstract

Encapsulating peritoneal sclerosis (EPS) is a serious complication of long-term continuous peritoneal dialysis therapy. The progression of EPS has been classified into four stages by Kawanishi and colleagues: pre-EPS, and the inflammatory, encapsulating, and ileus stages. The key issue is how to diagnose EPS early enough to allow for curative treatment. In this article, we review the mechanisms of peritoneal fibrosis, especially from the perspective of collagen synthesis, and the potential role of that fibrosis in the pathogenesis of EPS.

Entities:  

Mesh:

Year:  2005        PMID: 16300272

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  4 in total

1.  Adipose tissue behavior is distinctly regulated by neighboring cells and fluid flow stress: a possible role of adipose tissue in peritoneal fibrosis.

Authors:  Shigehisa Aoki; Kazuma Udo; Hiroyuki Morimoto; Satoshi Ikeda; Toshiaki Takezawa; Kazuyoshi Uchihashi; Aki Nishijima-Matsunobu; Mitsuru Noguchi; Hajime Sugihara; Shuji Toda
Journal:  J Artif Organs       Date:  2013-03-24       Impact factor: 1.731

2.  CD147 expression in peritoneal injury.

Authors:  Harald Seeger; Joerg Latus; Daniel Kitterer; M Dominik Alscher; Dagmar Biegger; Jin Chen; Ilka Edenhofer; Rudolf P Wüthrich; Stephan Segerer
Journal:  Clin Exp Nephrol       Date:  2017-05-27       Impact factor: 2.801

3.  Chondroitin sulfate prevents peritoneal fibrosis in mice by suppressing NF-κB activation.

Authors:  Shinichi Abe; Yoko Obata; Satoru Oka; Takehiko Koji; Tomoya Nishino; Koichi Izumikawa
Journal:  Med Mol Morphol       Date:  2016-02-15       Impact factor: 2.309

4.  Astragalus membranaceus inhibits peritoneal fibrosis via monocyte chemoattractant protein (MCP)-1 and the transforming growth factor-β1 (TGF-β1) pathway in rats submitted to peritoneal dialysis.

Authors:  Zhenghong Li; Lu Zhang; Weiming He; Changle Zhu; Jinsong Yang; Meixiao Sheng
Journal:  Int J Mol Sci       Date:  2014-07-22       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.